UB
BIO icon

UMB Bank’s Bio-Rad Laboratories Class A BIO Stock Holding History

UMB Bank’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$66.6K Buy
227
+15
+7% +$4.25K ﹤0.01% 1204
2026
Q1 		$59.1K Sell
212
-25
-11% -$7.2K ﹤0.01% 1192
2025
Q4 		$71.8K Buy
237
+30
+14% +$9.36K ﹤0.01% 1099
2025
Q3 		$58K Buy
207
+40
+24% +$10.9K ﹤0.01% 1098
2025
Q2 		$40.3K Buy
167
+79
+90% +$18.7K ﹤0.01% 1188
2025
Q1 		$21.4K Sell
88
-21
-19% -$6.32K ﹤0.01% 1306
2024
Q4 		$35.8K Buy
109
+32
+42% +$10.9K ﹤0.01% 1044
2024
Q3 		$25.8K Buy
77
+45
+141% +$14.3K ﹤0.01% 1114
2024
Q2 		$8.74K Buy
32
+31
+3,100% +$9.02K ﹤0.01% 1294
2024
Q1 		$346 Buy
+1
New +$329 ﹤0.01% 2060
2023
Q4 		– Sell
-9
Closed -$3.23K – 1619
2023
Q3 		$3.23K Buy
+9
New +$3.47K ﹤0.01% 1479
2023
Q1 		– Sell
-2
Closed -$1K – 1709
2022
Q4 		$1K Sell
2
-71
-97% -$28.7K ﹤0.01% 1597
2022
Q3 		$31K Sell
73
-16
-18% -$7.98K ﹤0.01% 979
2022
Q2 		$44K Buy
89
+16
+22% +$8.33K ﹤0.01% 946
2022
Q1 		$41K Sell
73
-76
-51% -$45.8K ﹤0.01% 1020
2021
Q4 		$113K Buy
+149
New +$112K ﹤0.01% 783

Other funds holding BIO

First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

UMB Bank's BIO Position: Q2 2026 in Review

UMB Bank increased its Bio-Rad Laboratories Class A (BIO) stake by 7.1% in Q2 2026, buying an estimated $4.25K and bringing the position to 227 shares worth $66.6K. The position accounts for ﹤0.01% of the portfolio, ranked #1204.

UMB Bank first reported a position in BIO in Q4 2021 and has held it in 16 quarters since. The position peaked at $113K in Q4 2021. 398 funds tracked by Wall St. Rank hold BIO as of Q2 2026.

  • UMB Bank held 227 shares of Bio-Rad Laboratories Class A worth $66.6K as of Q2 2026.
  • UMB Bank bought 15 Bio-Rad Laboratories Class A shares in Q2 2026, an estimated $4.25K.
  • Bio-Rad Laboratories Class A made up ﹤0.01% of UMB Bank's portfolio in Q2 2026, its #1204 holding.
  • UMB Bank first reported a position in Bio-Rad Laboratories Class A in Q4 2021 and has held it in 16 quarters since.
  • UMB Bank's Bio-Rad Laboratories Class A position peaked at $113K in Q4 2021.
  • 398 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q2 2026.

Based on UMB Bank's 13F filing for Q2 2026, filed 13 Aug 2026.